Gene · 4176
Papers3,001
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,001
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Effect of Microwave and Radiofrequency Ablation (MWA/RFA) on Liver Volume in Patients with Primary and Secondary Liver Tumours: A Retrospective Analysis. | Cardiovasc Intervent Radiol | 2023 | 37430014 | PubTator, text mining | PubMed |
| Nerve growth factor receptor (Ngfr) induces neurogenic plasticity by suppressing reactive astroglial Lcn2/Slc22a17 signaling in Alzheimer's disease. | NPJ Regen Med | 2023 | 37429840 | PubTator, text mining | PubMed |
| Culturable fungi from urban soils in China II, with the description of 18 novel species in Ascomycota (Dothideomycetes, Eurotiomycetes, Leotiomycetes and Sordariomycetes). | MycoKeys | 2023 | 37425100 | PubTator, text mining | PubMed |
| Differential impact of BRAFV600E isoforms on tumorigenesis in a zebrafish model of melanoma. | Cell Biosci | 2023 | 37393328 | PubTator, text mining | PubMed |
| A novel camptothecin derivative, ZBH-01, exhibits superior antitumor efficacy than irinotecan by regulating the cell cycle. | J Transl Med | 2023 | 37386467 | PubTator, text mining | PubMed |
| Towards unravelling biological mechanisms behind radiation-induced oral mucositis via mass spectrometry-based proteomics. | Front Oncol | 2023 | 37384298 | PubTator, text mining | PubMed |
| HPV E6 inhibits E6AP to regulate epithelial homeostasis by modulating keratinocyte differentiation commitment and YAP1 activation. | PLoS Pathog | 2023 | 37379354 | PubTator, text mining | PubMed |
| Dedifferentiation and Proliferation of Artery Endothelial Cells Drive Coronary Collateral Development in Mice. | Arterioscler Thromb Vasc Biol | 2023 | 37345524 | PubTator, text mining | PubMed |
| A five-cuproptosis-related LncRNA Signature: predicting prognosis, assessing immune function & drug sensitivity in lung squamous cell carcinoma. | J Cancer | 2023 | 37325063 | PubTator, text mining | PubMed |
| A genome-wide screen reveals that Dyrk1A kinase promotes nucleotide excision repair by preventing aberrant overexpression of cyclin D1 and p21. | J Biol Chem | 2023 | 37301510 | PubTator, text mining | PubMed |
| The orf virus 129 protein can inhibit immune responses by interacting with host complement C1q binding protein in goat turbinate bone cells. | Vet Microbiol | 2023 | 37270925 | PubTator, text mining | PubMed |
| Anti-miR-93-5p therapy prolongs sepsis survival by restoring the peripheral immune response. | J Clin Invest | 2023 | 37261908 | PubTator, text mining | PubMed |
| Neural network and kinetic modelling of human genome replication reveal replication origin locations and strengths. | PLoS Comput Biol | 2023 | 37253070 | PubTator, text mining | PubMed |
| Identification of key enzalutamide-resistance-related genes in castration-resistant prostate cancer and verification of RAD51 functions. | Open Med (Wars) | 2023 | 37251536 | PubTator, text mining | PubMed |
| MCM10: An effective treatment target and a prognostic biomarker in patients with uterine corpus endometrial carcinoma. | J Cell Mol Med | 2023 | 37246638 | PubTator, text mining | PubMed |
| Chemomodulatory Effect of the Marine-Derived Metabolite "Terrein" on the Anticancer Properties of Gemcitabine in Colorectal Cancer Cells. | Mar Drugs | 2023 | 37233465 | PubTator, text mining | PubMed |
| Saponins of North Atlantic Sea Cucumber: Chemistry, Health Benefits, and Future Prospectives. | Mar Drugs | 2023 | 37233456 | PubTator, text mining | PubMed |
| Accurate Label-Free Quantification by directLFQ to Compare Unlimited Numbers of Proteomes. | Mol Cell Proteomics | 2023 | 37225017 | PubTator, text mining | PubMed |
| De novo MCM6 variants in neurodevelopmental disorders: a recognizable phenotype related to zinc binding residues. | Hum Genet | 2023 | 37198333 | PubTator, text mining | PubMed |
| The chromosomal instability 25 gene signature is identified in clear cell renal cell carcinoma and serves as a predictor for survival and Sunitinib response. | Front Oncol | 2023 | 37197417 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4176/papers?page=11